|
XPC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.925190E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.289900E-02 |
| Normal-vs-Stage2 |
7.250600E-01 |
| Normal-vs-Stage3 |
7.594600E-01 |
| Normal-vs-Stage4 |
5.226400E-01 |
| Stage1-vs-Stage2 |
4.414200E-01 |
| Stage1-vs-Stage3 |
1.913220E-01 |
| Stage1-vs-Stage4 |
4.363800E-01 |
| Stage2-vs-Stage3 |
8.809400E-01 |
| Stage2-vs-Stage4 |
8.903400E-01 |
| Stage3-vs-Stage4 |
7.260600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.823700E-02 |
| Normal-vs-AfricanAmerican |
1.525000E-01 |
| Normal-vs-Asian |
3.359400E-01 |
| Caucasian-vs-AfricanAmerican |
5.357400E-01 |
| Caucasian-vs-Asian |
7.365600E-01 |
| AfricanAmerican-vs-Asian |
4.411400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.839000E-01 |
| Normal-vs-Female |
1.383230E-01 |
| Male-vs-Female |
3.652800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.276000E-02 |
| Normal-vs-Age(41-60Yrs) |
9.162100E-02 |
| Normal-vs-Age(61-80Yrs) |
4.007400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.363600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.474800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.237400E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.577840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.138180E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.976420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.679200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.577100E-03 |
| Classical-VS-Follicular |
2.03229655326709E-11 |
| Classical-VS-Other |
3.598000E-01 |
| Classical-VS-Normal |
1.760100E-03 |
| Tall-VS-Follicular |
2.586500E-02 |
| Tall-VS-Other |
7.600400E-01 |
| Tall-VS-Normal |
7.571400E-01 |
| Follicular-VS-Other |
2.123000E-01 |
| Follicular-VS-Normal |
4.380400E-03 |
| Other-VS-Normal |
8.743200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.927400E-01 |
| Normal-vs-N1 |
7.870800E-01 |
| N0-vs-N1 |
9.954200E-01 |
|
|
